Sub menu

 
 

Review of cardiovascular safety of non-steroidal anti-inflammatory drugs

Version 2.1, October 2014
Last updated

A review has been carried out of the relevant medical literature published since 2005 and other relevant data relating to the cardiovascular risks associated with the use of the eight non-steroidal anti-inflammatory drugs (NSAIDs) diclofenac, naproxen, ibuprofen, celecoxib, etoricoxib, indomethacin, meloxicam and piroxicam.

How to access a pdf document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Supporting documents

Topics

This webpage on the TGA website was printed on 12 Sep 2024. Printed content may be out of date. For up-to-date information, always refer to the digital version: https://www.tga.gov.au/resources/resource/guidance/review-cardiovascular-safety-non-steroidal-anti-inflammatory-drugs

Help us improve the Therapeutic Goods Administration site